Rigel Pharmaceuticals reported $6.76M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4411M 325M
Anika Therapeutics ANIK:US 35.22M 785K
Biomarin Pharmaceutical BMRN:US $ 786.36M 9.69M
Bristol Myers Squibb BMY:US $ 2104M 9M
Daiichi Sankyo 4568:JP Y 217910M 6304M
Eli Lilly And LLY:US $ 3893M 7M
Halozyme Therapeutics HALO:US $ 47.76M 6.15M
Heron Therapeutics HRTX:US $ 56.47M 8.09M
Intrexon XON:US $ 12.73M 0.53M
Karyopharm Therapeutics KPTI:US $ 3.87M 232K
Macrogenics MGNX:US $ 4.6M 0.21M
Neurocrine Biosciences NBIX:US $ 29M 1.5M
Pfizer PFE:US $ 9979M 920M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Rigel Pharmaceuticals RIGL:US $ 6.76M 0.15M
Ultragenyx Pharmaceutical RARE:US $ 17.81M 1.58M
Veracyte VCYT:US $ 12.37M 1.15M